This Unstoppable Healthcare Stock Just Made a Move in AI: Time to Buy?

Recent breakthroughs in artificial intelligence (AI) are producing tangible results, and not just in the tech industry, although companies in that sector tend to dominate the AI headlines. Even in healthcare, the technology can help boost productivity and efficiency. That's why many healthcare companies are actively pursuing various AI initiatives.Eli Lilly (NYSE: LLY), one of the largest companies in the sector by market cap, recently announced a move along those lines. Let's see what that could mean for the company's prospects.Developing novel medicines is expensive and time-consuming. Most drugs that reach the clinical trial phase, which typically involves three stages and costs hundreds of millions of dollars, never make it to the market.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool